P-glycoprotein efflux transporter: a key to pharmacokinetic modeling for methadone clearance in fetuses

被引：1
|
作者：
Ho, Harvey [1 ]
Zhang, En [2 ]
机构：
[1] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand
[2] Chongqing Food & Drug Control Inst, Chongqing, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷
关键词：
methadone; opioids; PBPK; P-glycoprotein; model; IN-VIVO; TRANSPLACENTAL TRANSFER; PLACENTAL-TRANSFER; BUPRENORPHINE; DISPOSITION; METABOLISM; MORPHINE; RAT;
D O I：
10.3389/fphar.2023.1182571
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Effects of Natural Polyphenols on the Expression of Drug Efflux Transporter P-Glycoprotein in Human Intestinal Cells
    Nabekura, Tomohiro
    Kawasaki, Tatsuya
    Furuta, Michi
    Kaneko, Tomoji
    Uwai, Yuichi
    ACS OMEGA, 2018, 3 (02): : 1621 - 1626
  • [32] Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein
    Nabekura, Tomohiro
    Kawasaki, Tatsuya
    Jimura, Misuzu
    Mizuno, Koichi
    Uwai, Yuichi
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2020, 21
  • [33] Endoxifen, the Active Metabolite of Tamoxifen, Is a Substrate of the Efflux Transporter P-Glycoprotein (Multidrug Resistance 1)
    Teft, Wendy A.
    Mansell, Sara E.
    Kim, Richard B.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (03) : 558 - 562
  • [34] Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein
    Zhu, Hao-Jie
    Wang, Jun-Sheng
    Donovan, Jennifer L.
    Jiang, Yan
    Gibson, Bryan B.
    DeVane, C. Lindsay
    Markowitz, John S.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 578 (2-3) : 148 - 158
  • [35] Pharmacokinetic Modeling of the Impact of P-glycoprotein on Ondansetron Disposition in the Central Nervous System
    Manting Chiang
    Hyun-moon Back
    Jong Bong Lee
    Sarah Oh
    Tiffany Guo
    Simone Girgis
    Celine Park
    Simon Haroutounian
    Leonid Kagan
    Pharmaceutical Research, 2020, 37
  • [36] Pharmacokinetic Modeling of the Impact of P-glycoprotein on Ondansetron Disposition in the Central Nervous System
    Chiang, Manting
    Back, Hyun-moon
    Lee, Jong Bong
    Oh, Sarah
    Guo, Tiffany
    Girgis, Simone
    Park, Celine
    Haroutounian, Simon
    Kagan, Leonid
    PHARMACEUTICAL RESEARCH, 2020, 37 (10)
  • [37] Pharmacokinetic and pharmacodynamic implications of P-glycoprotein modulation
    Matheny, CJ
    Lamb, MW
    Brouwer, KLR
    Pollack, GM
    PHARMACOTHERAPY, 2001, 21 (07): : 778 - 796
  • [38] Molecular analysis of the multidrug transporter, P-glycoprotein
    Germann, UA
    Chambers, TC
    CYTOTECHNOLOGY, 1998, 27 (1-3) : 31 - 60
  • [39] The regulatory effects of mitragynine on P-glycoprotein transporter
    Abduraman, Muhammad Asyraf
    Amanah, Azimah
    Hamid, Shahrul Bariyah Sahul
    Abdullah, Mohammad Farris Iman Leong
    Sulaiman, Shaida Fariza
    Tan, Mei Lan
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2024,
  • [40] Interaction of the P-Glycoprotein Multidrug Transporter with Sterols
    Clay, Adam T.
    Lu, Peihua
    Sharom, Frances J.
    BIOCHEMISTRY, 2015, 54 (43) : 6586 - 6597
12345